AI Drug
Insilico Medicine Reports Breakthrough Phase IIa Results for AI-Driven IPF Drug ISM001-055
2024-11-19
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets
2022-03-24
AI Technology Revamping Drug Development! VIRTUALMAN to Demonstrate Powerful Solutions in BIO Asia-Taiwan 2021
2021-07-15Partner
Combating the Pandemic via AI and Diagnostics: Highlights from the “TAIWAN is Helping: AI x Pandemic Prevention Online Forum”
2020-08-11Partner